NR1H4 and chronic thromboembolic pulmonary hypertension: Last, our results showed that improvement in HRR1 was associated with improvement in the well-validated markers of CTEPH severity, indicating that HRR1 might serve as a biomarker which could monitor the efficacy of BPA sessions.